Interleukin‐5 alleviates cardiac remodelling via the STAT3 pathway in angiotensin II ‐infused mice
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.18493 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Caijie Shen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, The First Affiliated Hospital of Ningbo University, Ningbo, China. Hauptthemen laut MEDLINE: Angiotensin II, STAT3 Transcription Factor, Mice, Knockout, Ventricular Remodeling. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Ningbo province public welfare project, the Key Technology R&D Program of Ningbo, the Plan of Science and Technology on Medical and Health in Zhejiang Province.
Abstract (Originalsprache)
Interleukin‐5 (IL‐5) has been reported to be involved in cardiovascular diseases, such as atherosclerosis and cardiac injury. This study aimed to investigate the effects of IL‐5 on cardiac remodelling. Mice were infused with angiotensin II (Ang II), and the expression and source of cardiac IL‐5 were analysed. The results showed that cardiac IL‐5 expression was time‐ and dose‐dependently decreased after Ang II infusion, and was mainly derived from cardiac macrophages. Additionally, IL‐5‐knockout (IL‐5−/−) mice were used to observe the effects of IL‐5 knockout on Ang II‐induced cardiac remodelling. We found knockout of IL‐5 significantly increased the expression of cardiac hypertrophy markers, elevated myocardial cell cross‐sectional areas and worsened cardiac dysfunction in Ang II‐infused mice. IL‐5 deletion also promoted M2 macrophage differentiation and exacerbated cardiac fibrosis. Furthermore, the effects of IL‐5 deletion on cardiac remodelling was detected after the STAT3 pathway was inhibited by S31‐201. The effects of IL‐5 on cardiac remodelling and M2 macrophage differentiation were reversed by S31‐201. Finally, the effects of IL‐5 on macrophage differentiation and macrophage‐related cardiac hypertrophy and fibrosis were analysed in vitro. IL‐5 knockout significantly increased the Ang II‐induced mRNA expression of cardiac hypertrophy markers in myocardial cells that were co‐cultured with macrophages, and this effect was reversed by S31‐201. Similar trends in the mRNA levels of fibrosis markers were observed when cardiac fibroblasts and macrophages were co‐cultured. In conclusions, IL‐5 deficiency promote the differentiation of M2 macrophages by activating the STAT3 pathway, thereby exacerbating cardiac remodelling in Ang II‐infused mice. IL‐5 may be a potential target for the clinical prevention of cardiac remodelling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, The First Affiliated Hospital of Ningbo University, Ningbo, China.
- Cardiovascular Medicine, The Second Affiliated Hospital of University of South China, Hengyang, China.
ORCID-Profile: Caijie Shen, Jianye Peng
Förderung
- the Ningbo province public welfare project
- the Key Technology R&D Program of Ningbo
- the Plan of Science and Technology on Medical and Health in Zhejiang Province
- the Natural Science Foundation of Ningbo
- Natural Science Foundation of Ningbo Municipality
Zitieren
APA
Shen, C., Wu, N., Chen, X., Peng, J., Feng, M., Wang, J., & Yu, Y. (2024). Interleukin‐5 alleviates cardiac remodelling via the STAT3 pathway in angiotensin II ‐infused mice. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18493
Vancouver
Shen C, Wu N, Chen X, Peng J, Feng M, Wang J, et al. Interleukin‐5 alleviates cardiac remodelling via the STAT3 pathway in angiotensin II ‐infused mice. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18493
BibTeX
@article{Shen2024,
author = {Shen, Caijie and Wu, Nan and Chen, Xiaomin and Peng, Jianye and Feng, Mingjun and Wang, Jian and Yu, Yibo},
title = {Interleukin‐5 alleviates cardiac remodelling via the STAT3 pathway in angiotensin II ‐infused mice},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.18493}
}
EUVIMED